Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.

导出 LinkOut

翻译打印收藏纠错

作者： Quitterie,Reynaud ^[1] ; Isabelle,Durieu ^[2] ; Marine,Dutertre ^[1] ; Stanislas,Ledochowski ^[3] ; Stéphane,Durupt ^[1] ; Anne-Sophie,Michallet ^[4] ; Denis,Vital-Durand ^[1] ; Jean-Christophe,Lega ^[2]

作者单位： Department of Internal and Vascular Medicine, Centre Hospitalier Lyon Sud, Claude Bernard University Lyon 1, France. ^[1] Department of Internal and Vascular Medicine, Centre Hospitalier Lyon Sud, Claude Bernard University Lyon 1, France; UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, CNRS, Claude Bernard University Lyon 1, France. ^[2] Anesthesiology and Critical Care Department, Centre Hospitalier Lyon Sud, Claude Bernard University Lyon 1, France. ^[3] Department of Hematology, Centre Hospitalier Lyon Sud, Claude Bernard University Lyon 1, France. ^[4]

关键词 Autoimmune hemolytic anemia Cold agglutinin disease Complete response Overall response rate Rituximab Warm autoimmune hemolytic anemia

主题词成年人(Adult);贫血, 溶血性, 自身免疫性(Anemia, Hemolytic, Autoimmune);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);儿童(Child);人类(Humans);脾切除术(Splenectomy)

DOI 10.1016/j.autrev.2014.11.014

PMID 25497766

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交